![Jennifer Low](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Low
Corporate Officer/Principal at
23andMe, Inc.
Profile
Jennifer Low currently works at 23andMe, Inc., as Head-Therapeutics Development from 2018.
Dr. Low also formerly worked at Genentech, Inc., as Senior Group Medical Director-Product Development from 2006 to 2014, Roche Holding AG, as Member, 23andMe Holding Co., as Head-Therapeutics Development, National Cancer Institute, as Senior Investigator, and Loxo Oncology, Inc., as Chief Medical Officer, EVP-Research & Development from 2014 to 2016.
Dr. Low received her graduate degree from Duke University, undergraduate degree from California Institute of Technology, and doctorate degree from Georgetown University.
Jennifer Low active positions
| Companies | Position | Start |
|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Corporate Officer/Principal | 2017-12-31 |
Former positions of Jennifer Low
| Companies | Position | End |
|---|---|---|
| CHROME HOLDING CO. | Corporate Officer/Principal | 2024-12-31 |
| LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 2015-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2013-12-31 |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Training of Jennifer Low
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
23andMe Holding Co.
 23andMe Holding Co. BiotechnologyHealth Technology Operates as a genetic testing company | Health Technology |
- Stock Market
- Insiders
- Jennifer Low
